SCHEMBL28333332

SCHEMBL28333332

CNCC(C)(N)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.46
KCNN4 O15554 3/20 0.44
BCDIN3D Q7Z5W3 3/20 0.43
SLC6A2 P23975 1/20 0.41
TACR1 P25103 1/20 0.41
MAPK1 P28482 1/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
CYP2D6 P10635 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.38
CYP3A4 P08684 1/20 0.38
KIF11 P52732 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27016733 1.00 TAAR1 (0.46) TAAR1KCNN4BCDIN3DSLC6A2TACR1
SCHEMBL2903242 0.84 KCNN4 (0.46) TAAR1KCNN4SLC6A2MAPK1MAPT
SCHEMBL8028843 0.81 TAAR1 (0.56) TAAR1KCNN4MAPK1MAPTLMNA
SCHEMBL13141207 0.81 TAAR1 (0.42) TAAR1KCNN4SLC6A2TACR1KMT2A
SCHEMBL2173457 0.79 KIF11 (0.43) TAAR1MAPK1KMT2AKIF11
SCHEMBL10145455 0.79 KCNN4 (0.46) TAAR1KCNN4MAPK1MAPTLMNA
SCHEMBL155932 0.78 TAAR1 (0.52) TAAR1KCNN4SLC6A2TACR1MAPK1
SCHEMBL12393357 0.78 MAPT (0.46) TAAR1KCNN4MAPK1MAPTLMNA
SCHEMBL11431197 0.77 TAAR1 (0.52) TAAR1KCNN4SLC6A2TACR1CYP2D6
SCHEMBL18663438 0.77 KCNN4 (0.41) TAAR1KCNN4SLC6A2MAPTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110546150-B Pyrazolyl-containing tricyclic derivatives, preparation method and application thereof 江苏豪森药业集团有限公司 2021-12-21 CN disclosed
CN-110546150-A Pyrazolyl-containing tricyclic derivatives, preparation method and application thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD 2019-12-06 CN disclosed